Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy (Q34557198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

main subject

IgA glomerulonephritis

4 references

13 March 2019

30 June 2019

27 November 2019

13 December 2019

1 reference

27 November 2019

1 reference

13 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

George Seki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Tomonosuke Someya

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michio Nagata

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Toshiro Fujita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

1 reference

24 January 2011

6 references

13 March 2019

30 June 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

29 May 2020

Clinical and Developmental Immunology

6 references

13 March 2019

30 June 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

29 May 2020

2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

470803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

22 January 2020

copyright license

4 references

13 March 2019

30 June 2019

27 November 2019

on focus list of Wikimedia project

13 December 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Long-term study of mycophenolate mofetil treatment in IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Interactions of human mesangial cells with IgA and IgA-containing immune complexes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Cloning and expression of human core 1 beta1,3-galactosyltransferase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Corticosteroids in IgA nephropathy: a randomised controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Predicting renal outcome in IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Role of transforming growth factor-beta in tissue injury and repair

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

[Intercapillary deposits of IgA-IgG]

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Low incidence of IgA nephropathy in blacks

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

The commonest glomerulonephritis in the world: IgA nephropathy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Interleukin 6 is an autocrine growth factor for mesangial cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

IgA immune complexes in Henoch-Schönlein purpura

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034910

Protein glycosylation: chaperone mutation in Tn syndrome

7 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Interaction between variants of two glycosyltransferase genes in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Resolution of Henoch-Schönlein purpura nephritis after acquired IgA deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Genome-Wide Linkage Scan of a Large Family with IgA Nephropathy Localizes a Novel Susceptibility Locus to Chromosome 2q36

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F470803

Clinical outcome of Schönlein-Henoch purpura nephritis in children

21 January 2018

1 reference

12 December 2020

IgA myeloma presenting as Henoch-Schönlein purpura with nephritis

1 reference

12 December 2020

Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients

1 reference

12 December 2020

1 reference

12 December 2020

Immunoglobulin A multiple myeloma presenting with Henoch-Schönlein purpura associated with reduced sialylation of IgA1

1 reference

12 December 2020

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation

1 reference

12 December 2020

IgA nephropathy in blacks and Indians of Natal

1 reference

12 December 2020

Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass

1 reference

12 December 2020

Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys

1 reference

12 December 2020

Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1

1 reference

12 December 2020

PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis

1 reference

12 December 2020

Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study

1 reference

12 December 2020

Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG

1 reference

12 December 2020

Donor-transmitted IgA nephropathy: Long-term follow-up of kidney donors and recipients

1 reference

12 December 2020

Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis

1 reference

12 December 2020

A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group

1 reference

12 December 2020

Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy

1 reference

12 December 2020

IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

1 reference

12 December 2020

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels

1 reference

12 December 2020

Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial

1 reference

12 December 2020

Is sialylation of IgA the agent provocateur of IgA nephropathy?

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/470803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318178%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

21318178

1 reference